|
|
41
|
|
|
A2313
|
|
|
NEURONTIN 300MG CAP (PFI) GABAPENTIN (C)
|
|
|
GABAPENTIN
|
|
|
NEURONTIN
|
|
|
100'S
|
|
|
C
|
|
|
151.44
|
|
|
1.5144
|
|
|
300MG
|
|
|
CAP
|
|
|
180
|
|
|
BOX
|
|
|
PFI
|
|
|
PFIZER CORPORATION
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
B
|
|
|
Anti-Epileptic
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
N
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|